Amlodipine besylate and Skin induration - a phase IV clinical study of FDA data

Summary:

Skin induration is reported as a side effect among people who take Amlodipine besylate (amlodipine besylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Magnevist, and have Nuclear magnetic resonance imaging brain.

The phase IV clinical study analyzes which people have Skin induration when taking Amlodipine besylate. It is created by eHealthMe based on reports of 71,608 people who have side effects when taking Amlodipine besylate from the FDA, and is updated regularly.

What is Amlodipine besylate?

Amlodipine besylate has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 75,293 Amlodipine besylate users. Check the latest studies of Amlodipine besylate.

What is Skin induration?

Skin induration (an abnormally hard spot or area on the skin) is found to be associated with 519 drugs and 500 conditions by eHealthMe. Check the latest studies of Skin induration.

On Jul, 06, 2026

71,608 people reported to have side effects when taking Amlodipine besylate.
Among them, 34 people (0.05%) have Skin induration.

Could Amlodipine besylate cause Skin induration?

Among these 34 people:

How long have people been on Amlodipine besylate when they have Skin induration? *

What is the gender of people who have Skin induration when taking Amlodipine besylate? *

female: 64.71 %
male: 35.29 %

What is the age of people who have Skin induration when taking Amlodipine besylate? *

What are other drugs people take besides Amlodipine besylate? *

What are other side effects people have besides Skin induration? *

Rashes (redness): 26 people, 76.47%
Pain: 23 people, 67.65%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 21 people, 61.76%
Weakness: 18 people, 52.94%
Joint Pain: 18 people, 52.94%
Mobility Decreased (ability to move is reduced): 16 people, 47.06%
Itching: 15 people, 44.12%
Skin Hypertrophy (skin cells enlarges): 14 people, 41.18%
Oedema Peripheral (superficial swelling): 14 people, 41.18%
General Physical Health Deterioration (weak health status): 14 people, 41.18%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 5 people, 14.71%
Immunodeficiency: 4 people, 11.76%
Primary Immunodeficiency Syndrome: 4 people, 11.76%
Nuclear Magnetic Resonance Imaging Abdominal: 4 people, 11.76%
Immunodeficiency Common Variable: 4 people, 11.76%
Neuroendocrine Tumor: 3 people, 8.82%
Joint Swelling: 3 people, 8.82%
Joint Pain: 3 people, 8.82%
Pain: 2 people, 5.88%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine besylate and have Skin induration?

- Check whether Skin induration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amlodipine besylate:

Amlodipine besylate (75,293 reports)

Skin induration treatments and more:

Skin induration (3,079 reports)

Browse all side effects of Amlodipine besylate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin induration:

Skin induration (519 drugs)

Browse all the conditions that are associated with Skin induration:

Skin induration (500 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine besylate) and Amlodipine besylate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.